Archive · 20 Jul 2026
India Approves First Dengue Vaccine QDENGA
India has approved its first dengue vaccine called QDENGA.
This vaccine is made by a company called Takeda and can protect people from all four types of dengue virus.
Unlike older vaccines, you don't need a blood test before getting it.
The vaccine is given in two doses, three months apart.
It has been shown to be very effective in preventing serious cases of dengue.
India is one of the countries with the most dengue cases, so this vaccine is a big help.
The exact price in India isn't known yet, but the company is working with an Indian partner to make it more affordable.
India's first dengue vaccine, QDENGA, has been approved by the CDSCO.
QDENGA protects against all four dengue virus serotypes and does not require pre-vaccination blood tests.
The vaccine is administered in two doses, three months apart, and has shown 84% effectiveness against hospitalisation due to dengue.
QDENGA has been approved in over 40 countries and is recommended by the WHO for high dengue burden areas.
The cost of QDENGA in India is yet to be announced, but local manufacturing may help reduce prices.
- Who
- Indian regulatory authorities and Takeda Pharmaceutical Company
- What
- Approval of QDENGA, India's first dengue vaccine
- When
- Recently approved by CDSCO
- Where
- India
- Why
- To combat the high burden of dengue cases in India
- Vaccine Name
- QDENGA (TAK-003)
- Developer
- Takeda
- Type
- Live-attenuated tetravalent vaccine
- Protection
- All four dengue virus serotypes
- Doses
- Two doses, three months apart
- Effectiveness
- 84% against hospitalisation, 61% overall
- Approval Status
- Approved in over 40 countries
- Manufacturing Partner in India
- Biological E
Sources
India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained
What Is QDENGA? India Gets Its First Dengue Vaccine As Cases Continue To Rise; Know Availability, Benefits And Key Facts
